CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Call for Patient Input and Clinical Experts: esketamine hydrochloride

Published on: May 27, 2019
Result type: News

CADTH has received the following notice(s) of pending drug submission(s).

Brand name TBC
Generic name esketamine hydrochloride
Manufacturer Janssen Inc.
Indication(s) Major depressive disorder (MDD), adults
Project Number SR0621-000
Call for patient input 2019-05-27
Patient input deadline 2019-07-16
Submit patient input Submit
Register as Clinical Expert Register